Notable Analyst Rating Changes 07/23: (MDC) (ONXX) (BYD) Upgraded; (MAR) (VRSN) (WAG) Downgraded

UPGRADES
Goldman Sachs adds M.D.C. Holdings (NYSE: MDC) to its Conviction Buy List with a price target of $50.00 (from $34.00). Click Here for more color.

Jefferies raises Onyx Pharmaceuticals (Nasdaq: ONXX) from Hold to Buy, moving its price target from $55 up to $101. Click Here for more color.

Sterne Agee lifts Boyd Gaming (NYSE: BYD) from Underperform to Neutral with a price target of $6.70.

Goldman Sachs boosts KB Home (NYSE: KBH) from Neutral to Buy, increasing its price target from $10 to $15. Click Here for more color.

For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades

DOWNGRADES
Goldman Sachs removes Marriott International (NYSE: MAR) from its Conviction Buy List, but kept a Buy with a price target of $43.

Citi trims VeriSign (Nasdaq: VRSN) from Buy to Neutral.

UBS lowers Walgreen (NYSE: WAG) from Buy to Neutral.

Macquarie cuts Kinross Gold (NYSE: KGC) from Outperform to Neutral.

For daily real-time Downgrades go to http://www.streetinsider.com/downgrades

NEW COVERAGE
Tesaro (Nasdaq: TSRO) started by several firms Monday:

• Leerink Swann with an Outperform and $20 price target. Click Here for more color;
  
  
• Baird at Outperform and $19 price target. Click Here for more color;
  
  
• Citi with a Buy and $21 price target; and
  
  
• Morgan Stanley with a Overweight and $19 target.

EQT Midstream Partners (NYSE: EQM) initiated by five today:

• Credit Suisse at Outperform;
  
  
• Barclays with a Overweight and $29 target;
  
  
• BofA/Merrill Lynch with a Buy and $29 target;
  
  
• JPMorgan with a Overweight and $29 price target; and
  
  
• Deutsche Bank with a Hold and $27 price target. Click Here for more color.

Goldman Sachs assumes IMAX Corp. (NYSE: IMAX) at Buy, with a $30 price target. Click Here for more color.

EXA Corp. (Nasdaq: EXA) started by a slew of firms Monday:

• Stifel Nicolaus at Buy, with a price target of $16;
  
  
• Baird with a Outperform and price target of $13;
  
  
• Canaccord Genuity at Buy and $13 price target; and
  
  
• Needham & Company with a Buy and $14 target. Click Here for more color.

For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage

Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• KKR & Co. (KKR) agreed to acquire Immedica Pharma
• Montrose Environmental Group Announces Pricing of Public Offering of Shares
• Intra-Cellular Therapies (ITCI) Prices Public Offering of Common Stock